82 results
8-K
EX-10.1
ENTA
Enanta Pharmaceuticals Inc
27 Apr 23
Non-Dilutive and Strengthens Balance Sheet
4:43pm
to Purchaser that such reimbursement was made.
(e) Remittances. All remittances pursuant to this Section 6.2 shall be made (i) without set-off … deduction (and reimbursement to the Royalty Parties) of all costs and expenses (including the fees and expenses of the independent certified public
424B5
kam8io5t n6e9owmsg9
26 Aug 22
Prospectus supplement for primary offering
4:06pm
8-K
EX-10.2
qj89 n5iylime58
17 May 22
Entry into a Material Definitive Agreement
4:37pm
8-K
EX-10.3
5csgdn
17 May 22
Entry into a Material Definitive Agreement
4:37pm
8-K
EX-99.1
bnmflr
22 Nov 21
Results of Operations and Financial Condition
4:05pm
8-K
EX-99.1
emt9iagd og820l
5 Aug 21
Results of Operations and Financial Condition
4:03pm
8-K
EX-10.1
mqe7re
5 Feb 21
Other Events
4:31pm
DEFR14A
9yey8xtv5i21l53cta
28 Jan 21
Revised proxy
4:01pm